Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

A Review of the Impact of Neoadjuvant Chemotherapy on Breast Surgery Practice and Outcomes.

O'Halloran N, Lowery A, Curran C, McLaughlin R, Malone C, Sweeney K, Keane M, Kerin M.

Clin Breast Cancer. 2019 Oct;19(5):377-382. doi: 10.1016/j.clbc.2019.04.011. Epub 2019 May 2.

PMID:
31227416
2.

Breast conserving therapy after neoadjuvant chemotherapy; data from the Dutch Breast Cancer Audit.

Spronk PER, Volders JH, van den Tol P, Smorenburg CH, Vrancken Peeters MTFD.

Eur J Surg Oncol. 2019 Feb;45(2):110-117. doi: 10.1016/j.ejso.2018.09.027. Epub 2018 Oct 17.

PMID:
30348601
3.

Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtype- Breast Cancer.

Kim HS, Yoo TK, Park WC, Chae BJ.

J Breast Cancer. 2019 Aug 19;22(3):412-424. doi: 10.4048/jbc.2019.22.e35. eCollection 2019 Sep.

4.

National Trends in the Use of Neoadjuvant Chemotherapy for Hormone Receptor-Negative Breast Cancer: A National Cancer Data Base Study.

Puig CA, Hoskin TL, Day CN, Habermann EB, Boughey JC.

Ann Surg Oncol. 2017 May;24(5):1242-1250. doi: 10.1245/s10434-016-5733-y. Epub 2016 Dec 20.

PMID:
28000076
5.

Combination of breast imaging parameters obtained from 18F-FDG PET and CT scan can improve the prediction of breast-conserving surgery after neoadjuvant chemotherapy in luminal/HER2-negative breast cancer.

Grapin M, Coutant C, Riedinger JM, Ladoire S, Brunotte F, Cochet A, Humbert O.

Eur J Radiol. 2019 Apr;113:81-88. doi: 10.1016/j.ejrad.2019.02.005. Epub 2019 Feb 7.

PMID:
30927964
6.

Determinants of short and long term outcomes in patients undergoing immediate breast reconstruction following neoadjuvant chemotherapy.

Wengler CA, Valente SA, Al-Hilli Z, Woody NM, Muntean JH, Abraham J, Tendulkar RD, Djohan R, O'Rourke C, Crowe JP, Grobmyer SR.

J Surg Oncol. 2017 Dec;116(7):797-802. doi: 10.1002/jso.24741. Epub 2017 Jul 11.

PMID:
28699269
7.

The Shifting Paradigm for Breast Cancer Surgery in Patients Undergoing Neoadjuvant Chemotherapy.

Kantor O, Ajmani G, Wang CH, Datta A, Yao K.

Ann Surg Oncol. 2018 Jan;25(1):164-172. doi: 10.1245/s10434-017-6217-4. Epub 2017 Nov 10.

PMID:
29127538
8.

Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.

Cho JH, Park JM, Park HS, Park S, Kim SI, Park BW.

J Surg Oncol. 2013 Dec;108(8):531-6. doi: 10.1002/jso.23439. Epub 2013 Sep 30.

PMID:
24115142
9.

Patterns of Care in the Administration of Neo-adjuvant Chemotherapy for Breast Cancer. A Population-Based Study.

Vugts G, Maaskant-Braat AJ, Nieuwenhuijzen GA, Roumen RM, Luiten EJ, Voogd AC.

Breast J. 2016 May;22(3):316-21. doi: 10.1111/tbj.12568. Epub 2016 Mar 4.

PMID:
26945566
10.

Neoadjuvant Chemotherapy for Breast Cancer, Is Practice Changing? A Population-Based Review of Current Surgical Trends.

Graham PJ, Brar MS, Foster T, McCall M, Bouchard-Fortier A, Temple W, Quan ML.

Ann Surg Oncol. 2015 Oct;22(10):3376-82. doi: 10.1245/s10434-015-4714-x. Epub 2015 Jul 23.

PMID:
26202561
11.

The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.

Rusthoven CG, Rabinovitch RA, Jones BL, Koshy M, Amini A, Yeh N, Jackson MW, Fisher CM.

Ann Oncol. 2016 May;27(5):818-27. doi: 10.1093/annonc/mdw046. Epub 2016 Feb 9.

PMID:
26861597
12.

Rising rates of bilateral mastectomy with reconstruction following neoadjuvant chemotherapy.

Pollom EL, Qian Y, Chin AL, Dirbas FM, Asch SM, Kurian AW, Horst KC, Tsai CJ.

Int J Cancer. 2018 Dec 15;143(12):3262-3272. doi: 10.1002/ijc.31747. Epub 2018 Sep 27.

13.

Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer.

Truin W, Vugts G, Roumen RM, Maaskant-Braat AJ, Nieuwenhuijzen GA, van der Heiden-van der Loo M, Tjan-Heijnen VC, Voogd AC.

Ann Surg Oncol. 2016 Jan;23(1):51-7. doi: 10.1245/s10434-015-4603-3. Epub 2015 May 16.

14.

Lymphovascular invasion can be better than pathologic complete response to predict prognosis in breast cancer treated with neoadjuvant chemotherapy.

Ryu YJ, Kang SJ, Cho JS, Yoon JH, Park MH.

Medicine (Baltimore). 2018 Jul;97(30):e11647. doi: 10.1097/MD.0000000000011647.

15.

Neoadjuvant human epidermal growth factor receptor-2 targeted therapy in patients with locally advanced breast cancer.

Cho DH, Lee SK, Kim S, Choi MY, Jung SP, Lee J, Kim J, Koo MY, Bae SY, Kim JH, Kim JS, Ho KW, Lee JE, Nam SJ, Yang JH.

J Korean Surg Soc. 2013 May;84(5):273-80. doi: 10.4174/jkss.2013.84.5.273. Epub 2013 Apr 24.

16.

Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States.

Mougalian SS, Soulos PR, Killelea BK, Lannin DR, Abu-Khalaf MM, DiGiovanna MP, Sanft TB, Pusztai L, Gross CP, Chagpar AB.

Cancer. 2015 Aug 1;121(15):2544-52. doi: 10.1002/cncr.29348. Epub 2015 Apr 22.

17.

Current decisions on neoadjuvant chemotherapy for early breast cancer: Experts' experiences in the Netherlands.

Spronk PER, de Ligt KM, van Bommel ACM, Siesling S, Smorenburg CH, Vrancken Peeters MTFD; NABON Breast Cancer Audit.

Patient Educ Couns. 2018 Dec;101(12):2111-2115. doi: 10.1016/j.pec.2018.07.012. Epub 2018 Jul 18.

PMID:
30054106
19.

Rates of Neoadjuvant Chemotherapy and Oncoplastic Surgery for Breast Cancer Surgery: A French National Survey.

Clough KB, Acosta-MarĂ­n V, Nos C, Alran S, Rouanet P, Garbay JR, Giard S, Verhaeghe JL, Houvenaeghel G, Flipo B, Dauplat J, Dorangeon PH, Classe JM, Rouzier R, Bonnier P.

Ann Surg Oncol. 2015 Oct;22(11):3504-11. doi: 10.1245/s10434-015-4378-6. Epub 2015 Feb 10.

PMID:
25665949
20.

Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.

Franceschini G, Di Leone A, Natale M, Sanchez MA, Masett R.

Ann Ital Chir. 2018;89:290.

PMID:
30352955

Supplemental Content

Support Center